Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
FAQ
Mydecine Innovations Group 今天的股價是多少?▼
MYCO.CN 目前價格為 C$0.33 CAD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Mydecine Innovations Group 股價表現。
Mydecine Innovations Group 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Mydecine Innovations Group 的股票以代號 MYCO.CN 進行交易。
Mydecine Innovations Group 的股價在上漲嗎?▼
MYCO.CN 股票較上週上漲 +0%,本月上漲 +10%,但過去一年 Mydecine Innovations Group 下跌 -34%。
Mydecine Innovations Group 的市值是多少?▼
今天 Mydecine Innovations Group 的市值為 407,550
Mydecine Innovations Group 下一次財報日期是什麼時候?▼
Mydecine Innovations Group 將於 March 27, 2026 公布下一次財報。
Mydecine Innovations Group 去年的營收是多少?▼
Mydecine Innovations Group 去年的營收為 0CAD。
Mydecine Innovations Group 去年的淨利是多少?▼
MYCO.CN 去年的淨收益為 -6.3MCAD。
Mydecine Innovations Group 有多少名員工?▼
截至 February 07, 2026,公司共有 3 名員工。
Mydecine Innovations Group 位於哪個產業?▼
Mydecine Innovations Group從事於Health Care產業。
Mydecine Innovations Group 何時完成拆股?▼
Mydecine Innovations Group 上次拆股發生於 October 21, 2025,比例為 1:50。
Mydecine Innovations Group 的總部在哪裡?▼
Mydecine Innovations Group 的總部位於 CA 的 Vancouver。